# US 2026/0043057 A1 · Enzymatic synthesis of mycosporine-like amino acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0043057 A1
- Document ID: US20260043057A1
- Status: Published application
- Kind: A1
- Application number: 18/998,446
- Filed: 2023-07-26
- Published: 2026-02-12
- Earliest claimed: 2022-07-26
- Assignees: University of Florida Research Foundation, Inc.
- Applicants: University of Florida Research Foundation, Incorporated
- Inventors: Yousong Ding; Manyun Chen
- Web page: https://patentgrep.com/patent/US20260043057A1

## CPC

- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P 13/04: Alpha- or beta- amino acids {(other amino acids C12P13/005)}
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- C12N 1/20: Bacteria; Culture media therefor
- C12N 9/00: Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K8/66, A61Q11/00; medicinal preparations containing enzymes or proenzymes A61K38/43; enzyme containing detergent compositions C11D; {enzymes with nucleic acid structure, e.g. ribozymes, C12N15/113}); Processes for preparing, activating, inhibiting, separating or purifying enzymes (preparation of malt C12C1/00)
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/0073: {with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13}
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12N 9/1048: {Glycosyltransferases (2.4)}
- C12N 9/88: Lyases (4.)
- C12N 9/93: {Ligases (6)}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12P 13/001: {Amines; Imines}
- C12Y 201/01: Methyltransferases (2.1.1)
- C12Y 402/03: acting on phosphates (4.2.3)
- C12Y 603/02: Acid—amino-acid ligases (peptide synthases)(6.3.2)
- C12R 2001/19: Escherichia coli
- C12Y 114/11018: Phytanoyl-CoA dioxygenase (1.14.11.18)
- C12Y 603/02004: D-Alanine-D-alanine ligase (6.3.2.4)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention relates to methods of producing compounds of interest in a recombinant microorganism. In particular, the present invention relates to using a recombinant microorganism comprising a heterologous nucleic acid encoding one or more mycosporine-like amino acid (MAA) biosynthetic enzymes (e.g., MysH) to produce compounds of interest. Compositions comprising compounds produced using such methods are also provided herein. The present disclosure also provides methods of preventing sunburn, cancer, and chronic inflammatory diseases by administering such compositions to subjects in need thereof.

## Claims

### Claim 1

A method for producing a compound, comprising:
a) culturing a recombinant microorganism under conditions suitable for production of the compound; and
b) isolating the compound from the recombinant microorganism,
wherein the recombinant microorganism comprises a heterologous nucleic acid encoding one or more mycosporine-like amino acid (MAA) biosynthetic enzymes, wherein the one or more MAA biosynthetic enzymes comprise a phytanoyl-CoA dioxygenase (MysH), or a homolog thereof.

### Claim 2 (depends on 1)

The method of claim 1, wherein the phytanoyl-CoA dioxygenase comprises an amino acid sequence of any one of SEQ ID NOs: 1-11, or an amino acid sequence at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or at least 99% identical to the amino acid sequence of any one of SEQ ID NOs: 1-11.

### Claim 3 (depends on 1, 2)

The method of claim 1 or 2, wherein the one or more MAA biosynthetic enzymes further comprise a D-alanine-D-alanine ligase (MysD), or a homolog thereof.

### Claim 4 (depends on 3)

The method of claim 3, wherein the D-alanine-D-alanine ligase comprises an amino acid sequence of SEQ ID NO: 12, or an amino acid sequence at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or at least 99% identical to the amino acid sequence of SEQ ID NO: 12.

### Claim 5 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the one or more MAA biosynthetic enzymes further comprise an ATP-grasp enzyme (MysC), or a homolog thereof.

### Claim 6 (depends on 5)

The method of claim 5, wherein the ATP-grasp enzyme comprises an amino acid sequence of any one of SEQ ID NOs: 13-104 and 113-116, or an amino acid sequence at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or at least 99% identical to the amino acid sequence of any one of SEQ ID NOs: 13-104 and 113-116.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of any one of claims 1-6, wherein the one or more biosynthetic enzymes further comprise one or more enzymes selected from the group consisting of a dimethyl-4-deoxygadusol synthase (MysA), an O-methyltransferase (MysB), and a non-ribosomal peptide synthetase (NRPS)-like enzyme (MysE).

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of any one of claims 1-7, wherein the compound is a palythine analog.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method of any one of claims 1-8, wherein the compound has UV-modulating activity.

### Claim 10 (depends on 9)

The method of claim 9, wherein the UV-modulating activity comprises absorption of UV wavelengths between 310 and 362 nm.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the compound is of Formula (I), or a salt thereof:
wherein:
each of R1, R2, R3, and R4 is independently selected from the group consisting of —ORa, —(NH)Rb, and —N(Rb)2, wherein each instance of Ra is independently hydrogen or optionally substituted C1-6 alkyl and each instance of Rb is independently hydrogen or optionally substituted C1-6 alkyl; and
R5 is an amino acid.

### Claim 12 (depends on 11)

The method of claim 11, wherein R1 is —ORa, wherein Ra is optionally substituted C1-6 alkyl.

### Claim 13 (depends on 12)

The method of claim 12, wherein R1 is —OCH3.

### Claim 14 (depends on 11, 12, 13)

The method of any one of claims 11-13, wherein R2 is —NH2.

### Claim 15 (depends on 11, 12, 13, 14)

The method of any one of claims 11-14, wherein R3 is —OH.

### Claim 16 (depends on 11, 12, 13, 14, 15)

The method of any one of claims 11-15, wherein R4 is —OH.

### Claim 17 (depends on 11, 12, 13, 14, 15, 16)

The method of any one of claims 11-16, wherein R5 is threonine.

### Claim 18 (depends on 11, 12, 13, 14, 15, 16)

The method of any one of claims 11-16, wherein R5 is serine.

### Claim 19 (depends on 11, 12, 13, 14, 15, 16)

The method of any one of claims 11-16, wherein R5 is isoleucine.

### Claim 20 (depends on 11, 12, 13, 14, 15, 16)

The method of any one of claims 11-16, wherein R5 is methionine.

### Claim 21 (depends on 11, 12, 13, 14, 15, 16)

The method of any one of claims 11-16, wherein R5 is valine.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method of any one of claims 1-11, wherein the compound is of the formula:
or a salt thereof.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the compound is of the formula:
or a salt thereof.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The method of any one of claims 1-23, further comprising providing a substrate of the one or more mycosporine-like amino acid (MAA) biosynthetic enzymes to the recombinant microorganism.

### Claim 25 (depends on 24)

The method of claim 24, wherein the substrate is a compound of Formula (II), or a salt thereof:
wherein:
each of R1, R2, R3, and R4 is independently selected from the group consisting of —ORa, —(NH)Rb, and —N(Rb)2, wherein each instance of Ra is independently hydrogen or optionally substituted C1-6 alkyl and each instance of Rb is independently hydrogen or optionally substituted C1-6 alkyl; and
Y is O or NR5, wherein R5 is optionally substituted C1-6 alkyl, optionally substituted C1-6 alkenyl, or an amino acid.

### Claim 26 (depends on 25)

The method of claim 25, wherein R1 is —OH.

### Claim 27 (depends on 25)

The method of claim 25, wherein R1 is —OCH3.

### Claim 28 (depends on 25, 26, 27)

The method of any one of claims 25-27, wherein R2 is —OH.

### Claim 29 (depends on 25, 26, 27)

The method of any one of claims 25-27, wherein R2 is —NH2.

### Claim 30 (depends on 25, 26, 27)

The method of any one of claims 25-27, wherein R2 is —(NH)Rb, wherein Rb is optionally substituted alkyl.

### Claim 31 (depends on 30)

The method of claim 30, wherein R2 is —NHCH2CO2H.

### Claim 32 (depends on 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 25-31, wherein R3 is —OH.

### Claim 33 (depends on 25, 26, 27, 28, 29, 30, 31, 32)

The method of any one of claims 25-32, wherein R4 is —OH.

### Claim 34 (depends on 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any one of claims 25-33, wherein Y is O.

### Claim 35 (depends on 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any one of claims 25-33, wherein Y is NR5.

### Claim 36 (depends on 35)

The method of claim 35, wherein R5 is threonine.

### Claim 37 (depends on 35)

The method of claim 35, wherein R5 is serine.

### Claim 38 (depends on 35)

The method of claim 35, wherein R5 is isoleucine.

### Claim 39 (depends on 35)

The method of claim 35, wherein R5 is methionine.

### Claim 40 (depends on 35)

The method claim 35, wherein R5 is valine.

### Claim 41 (depends on 25)

The method of claim 25, wherein the substrate is of the formula:
or a salt thereof.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The method of any one of claims 1-41, wherein the one or more MAA biosynthetic enzymes further comprise a glycosyltransferase (GlyT), or a homolog thereof.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The method of any one of claims 1-42, wherein the recombinant microorganism is a species of bacteria or yeast.

### Claim 44 (depends on 43)

The method of claim 43, wherein the bacteria is a species of cyanobacteria.

### Claim 45 (depends on 43)

The method of claim 43, wherein the bacteria is a species from the human microbiome.

### Claim 46 (depends on 43)

The method of claim 43, wherein the bacteria is E. coli.

### Claim 47

A recombinant microorganism comprising a heterologous nucleic acid encoding one or more mycosporine-like amino acid (MAA) biosynthetic enzymes, wherein the one or more MAA biosynthetic enzymes comprise a phytanoyl-CoA dioxygenase (MysH), or a homolog thereof.

### Claim 48 (depends on 47)

A method of producing a compound, comprising:
a) culturing the recombinant microorganism of claim 47 under conditions suitable for production of the compound; and
b) isolating the compound from the recombinant microorganism.

### Claim 49 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 48)

A composition comprising a compound produced by the method of any one of claims 1-46 or 48 and optionally an excipient.

### Claim 50 (depends on 49)

The composition of claim 49, wherein the composition is for topical administration.

### Claim 51 (depends on 49, 50)

The composition of claim 49 or 50, wherein the composition is formulated as a sunscreen.

### Claim 52 (depends on 49, 50)

The composition of claim 49 or 50, wherein the composition is formulated as a cosmetic.

### Claim 53 (depends on 49, 50, 51, 52)

A method of making the composition of any one of claims 49-52, comprising:
a) culturing a recombinant microorganism under conditions suitable for production of the compound;
b) isolating the compound from the recombinant microorganism,
wherein the recombinant microorganism comprises a heterologous nucleic acid encoding one or more mycosporine-like amino acid (MAA) biosynthetic enzymes, wherein the one or more MAA biosynthetic enzymes comprise a phytanoyl-CoA dioxygenase (MysH), or a homolog thereof, and
c) adding the compound to one or more excipients to produce the composition.

### Claim 54 (depends on 49, 50, 51, 52)

A method of administering a compound, comprising applying the composition of any one of claims 49-52 to a subject.

### Claim 55 (depends on 49, 50, 51, 52)

A method of preventing sunburn, comprising applying the composition of any one of claims 49-52 on the skin of a subject in need thereof.

### Claim 56 (depends on 49, 50, 51, 52)

A method of preventing cancer, comprising applying the composition of any one of claims 49-52 on the skin of a subject in need thereof.

### Claim 57 (depends on 49, 50, 51, 52)

A method of preventing or treating a chronic inflammatory disease, comprising administering the composition of any one of claims 49-52 to a subject in need thereof.

### Claim 58

A compound produced by:
a) culturing a recombinant microorganism under conditions suitable for production of the compound; and
b) isolating the compound from the recombinant microorganism,
wherein the recombinant microorganism comprises a heterologous nucleic acid encoding one or more mycosporine-like amino acid (MAA) biosynthetic enzymes, wherein the one or more MAA biosynthetic enzymes comprise a phytanoyl-CoA dioxygenase (MysH), or a homolog thereof.

### Claim 59 (depends on 58)

The compound of claim 58, wherein the compound is of Formula (I), or a salt thereof:
wherein:
each of R1, R2, R3, and R4 is independently selected from the group consisting of —ORa, —(NH)Rb, and —N(Rb)2, wherein each instance of Ra is independently hydrogen or optionally substituted C1-6 alkyl and each instance of Rb is independently hydrogen or optionally substituted C1-6 alkyl; and
R5 is an amino acid.

### Claim 60 (depends on 59)

The compound of claim 59, wherein R1 is —ORa, wherein Ra is optionally substituted C1-6 alkyl.

### Claim 61 (depends on 60)

The compound of claim 60, wherein R1 is —OCH3.

### Claim 62 (depends on 59, 60, 61)

The compound of any one of claims 59-61, wherein R2 is —NH2.

### Claim 63 (depends on 59, 60, 61, 62)

The compound of any one of claims 59-62, wherein R3 is —OH.

### Claim 64 (depends on 59, 60, 61, 62, 63)

The compound of any one of claims 59-63, wherein R4 is —OH.

### Claim 65 (depends on 59, 60, 61, 62, 63, 64)

The compound of any one of claims 59-64, wherein R5 is threonine.

### Claim 66 (depends on 59, 60, 61, 62, 63, 64, 65)

The compound of any one of claims 59-65, wherein R5 is serine.

### Claim 67 (depends on 59, 60, 61, 62, 63, 64, 65)

The compound of any one of claims 59-65, wherein R5 is isoleucine.

### Claim 68 (depends on 59, 60, 61, 62, 63, 64, 65)

The compound of any one of claims 59-65, wherein R5 is methionine.

### Claim 69 (depends on 59, 60, 61, 62, 63, 64, 65)

The compound of any one of claims 59-65, wherein, wherein R5 is valine.

### Claim 70 (depends on 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69)

The compound of any one of claims 59-69, wherein the compound is of the formula:
or a salt thereof.

### Claim 71 (depends on 58)

The compound of claim 58, wherein the compound is of the formula:
or a salt thereof.

### Claim 72 (depends on 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71)

A composition comprising the compound of any one of claims 58-71, or a salt thereof.

### Claim 73 (depends on 72)

The composition of claim 72, wherein the composition is for topical administration.

### Claim 74 (depends on 72, 73)

The composition of claim 72 or 73, wherein the composition is formulated as a sunscreen.

### Claim 75 (depends on 72, 73)

The composition of claim 72 or 73, wherein the composition is formulated as a cosmetic.

### Claim 76 (depends on 72, 73, 74, 75)

A method of administering a compound, comprising applying the composition of any one of claims 72-75 to a subject.

### Claim 77 (depends on 72, 73, 74, 75)

A method of preventing sunburn, comprising applying the composition of any one of claims 72-75 on the skin of a subject in need thereof.

### Claim 78 (depends on 72, 73, 74, 75)

A method of preventing cancer, comprising applying the composition of any one of claims 72-75 on the skin of a subject in need thereof.

### Claim 79 (depends on 72, 73, 74, 75)

A method of treating or preventing a chronic inflammatory disease, comprising applying the composition of any one of claims 72-75 on the skin of a subject in need thereof.
